Page 9 - Cytokinetics Incorporated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cytokinetics incorporated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cytokinetics Incorporated Today - Breaking & Trending Today

Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe

Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics Incorporated , Royalty Pharma ,

Raymond James Adjusts Price Target on Cytokinetics to $70 From $92, Maintains Outperform Rating

Cytokinetics has an average rating of outperform and price targets ranging from $60 to $122, according to analysts polled by Capital IQ.


Price: 48.67, Change: -10.57, Percent Change: -17.84
. ....

Cytokinetics Incorporated ,

Cytokinetics Announces Proposed Public Offering of Common Stock

Cytokinetics Announces Proposed Public Offering of Common Stock
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics Incorporated ,

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to…

Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to…
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Cytokinetics Incorporated , Royalty Pharma ,